JaySGiriMDMPH

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine

Interventional Cardiologist, Hospital of the University of Pennsylvania

Dr. Giri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Civic Center Blvd
East Pavilion, 2nd Floor
Philadelphia, PA 19104
Phone+1 215-615-4949

Dr. Jay Giri is a cardiologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania, Pennsylvania Hospital, and Philadelphia Veterans Affairs Medical Center. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice 13 years. He specializes in interventional cardiology, peripheral endovascular interventional cardiology, and vascular medicine and is experienced in valvular heart disease, interventional cardiology, cardiac catheterization, peripheral vascular disease, and minimally invasive cardiac surgery.

Massachusetts General HospitalFellowship, Interventional Cardiology, 2011 - 2012
University of Pennsylvania Health SystemFellowship, Interventional Cardiology, 2010 - 2011
University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2007 - 2010
Massachusetts General HospitalResidency, Internal Medicine, 2004 - 2007
Northwestern University The Feinberg School of MedicineClass of 2004

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among US Hospitals.
Ashwin S Nathan, Kevin F Kennedy, Kriyana P Reddy, Alexander C Fanaroff, Daniel M Kolansky
Journal of the American Heart Association. 2025-03-04
Revenues, costs, and contribution margins of major inpatient cardiovascular procedures within the Medicare population.
Kriyana P Reddy, Kaitlyn Shutlz, Lauren A Eberly, Sameed Ahmed M Khatana, Alexander C Fanaroff
American Heart Journal. 2025-03-01
Contribution margins and utilization of transcatheter aortic valve replacement versus surgical aortic valve replacement in the Medicare population.
Kriyana P Reddy, Kaitlyn Shultz, Lauren A Eberly, Sameed Ahmed M Khatana, Alexander C Fanaroff
American Heart Journal. 2025-03-01

Journal Articles

Performance of Hospitals When Assessing Disease-Based Mortality Compared with Procedural Mortality for Patients with Acute Myocardial Infarction
Ashwin S Nathan, Rishi K Wadhera, Deepak L Bhatt, Daniel M Kolansky, Ajay J Kirtane, Robert W Yeh, Tracy Y Wang, Jay Giri, JAMA Cardiology
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016
Daniel M Kolansky, Taisei Kobayashi, Peter W Groeneveld, Jay Giri, JAMA
Treatment of Submassive and Massive Pulmonary Embolism: A Clinical Practice Survey from the Second Annual Meeting of the Pulmonary Embolism Response Team Consortium
Kenneth Rosenfield, Geoffrey D Barnes, Michael R Jaff, Thomas M Todoran, Christopher Kabrhel, Rachel P Rosovsky, Jay Giri, Journal of Thrombosis and Thrombolysis

Lectures

Peri-Procedural Stroke with Carotid Artery Stenting How Low Can You Go?
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019

Prasugrel or Ticagrelor for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Does It Matter?May 2018
Is It Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation on Anticoagulation?April 2018

Peripheral Matters | Increasing Diversity in Clinical Trials: The ELEGANCE RegistryJanuary 6th, 2025
ELEGANCE Registry Studies Drug-Eluting Device Treatment of PAD in Underrepresented Minorities and WomenNovember 5th, 2024
Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism PatientsMay 22nd, 2023
Join now to see all